Guest guest Posted September 9, 2007 Report Share Posted September 9, 2007 (Cancer Decisions News Staff) Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #305 09/09/07 THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER NEW DOUBTS ON SAFETY OF 'TARGETED' DRUGS – PART II New doubts have been raised about the safety and efficacy of drugs known as angiogenesis inhibitors. These drugs are designed to block the development of new blood vessels within and around tumors. Without an effective and independent blood supply a tumor cannot grow bigger than the tip of a pencil. To read or listen to this week's newsletter, please click here or go to: http://www.cancerdecisions.com/090907.html To SUBSCRIBE TO OUR FREE NEWSLETTER: Please go to http://cancerdecisions.com/list/optin.php?form_id=8 and follow the instructions to be automatically added to this list. Thank you. CancerDecisions® PO Box 1076, Lemont, PA 16851 Phone Toll Free: 800-980-1234 | Fax: 814-238-5865 1996-2007 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.